OMDA logo

Omada Health, Inc. Stock Price

NasdaqGS:OMDA Community·US$860.2m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

OMDA Share Price Performance

US$13.18
-9.82 (-42.70%)
US$28.90
Fair Value
US$13.18
-9.82 (-42.70%)
54.4% undervalued intrinsic discount
US$28.90
Fair Value
Price US$13.18
AnalystConsensusTarget US$28.90
AnalystHighTarget US$33.00
AnalystLowTarget US$17.53

OMDA Community Narratives

AnalystConsensusTarget·
Fair Value US$28.9 54.4% undervalued intrinsic discount

GLP-1 Expansion And AI Integration Will Drive Long-Term Chronic Care Leadership

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AnalystHighTarget·
Fair Value US$33 60.1% undervalued intrinsic discount

GLP-1 And AI Care Platform Will Support Powerful Long Term Chronic Condition Tailwinds

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value US$17.53 24.8% undervalued intrinsic discount

GLP-1 Complexity And Rising Costs Will Challenge Virtual Care Scale Yet Eventually Support Returns

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$17.53
24.8% undervalued intrinsic discount
Revenue
26.56% p.a.
Profit Margin
5.35%
Future PE
60.33x
Price in 2029
US$11.96
US$33
60.1% undervalued intrinsic discount
Revenue
26.57% p.a.
Profit Margin
5.45%
Future PE
111.51x
Price in 2029
US$22.51
US$28.9
54.4% undervalued intrinsic discount
Revenue
23.17% p.a.
Profit Margin
5.45%
Future PE
105.98x
Price in 2028
US$19.72

Trending Discussion

Updated Narratives

OMDA logo

GLP-1 Complexity And Rising Costs Will Challenge Virtual Care Scale Yet Eventually Support Returns

Fair Value: US$17.53 24.8% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OMDA logo

GLP-1 And AI Care Platform Will Support Powerful Long Term Chronic Condition Tailwinds

Fair Value: US$33 60.1% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OMDA logo

GLP-1 Expansion And AI Integration Will Drive Long-Term Chronic Care Leadership

Fair Value: US$28.9 54.4% undervalued intrinsic discount
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

1 Risk
3 Rewards

Omada Health, Inc. Key Details

US$232.3m

Revenue

US$82.9m

Cost of Revenue

US$149.4m

Gross Profit

US$175.6m

Other Expenses

-US$26.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 05, 2026
-0.45
64.31%
-11.27%
0%
View Full Analysis

About OMDA

Founded
2011
Employees
868
CEO
Sean Duffy
WebsiteView website
www.omadahealth.com

Omada Health, Inc. provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. Omada Health, Inc. was incorporated in 2011 and is headquartered in South San Francisco, California.

Recent OMDA News & Updates

Is Omada Health, Inc. (NASDAQ:OMDA) Trading At A 34% Discount?

Jan 15
Is Omada Health, Inc. (NASDAQ:OMDA) Trading At A 34% Discount?

Recent updates

No updates